Bioengineered algal lipids enriched in structured medium- and long-chain triacylglycerols, linoleate, and sn-2 palmitate for human milk fat substitutes

Researchers engineered the oleaginous green alga *Auxenochlorella* to biosynthesize human milk fat substitutes enriched with structured medium- and long-chain triacylglycerols, linoleate, and sn-2 palmitate, thereby replicating the critical structural and compositional features of human milk fat for infant nutrition.

The Gist

Imagine that human breast milk is like a perfectly crafted, high-performance fuel designed specifically for a baby's growing engine. The most important part of this fuel is a special type of fat called triacylglycerols (TAGs). These fats provide more than half of the energy a baby needs to grow, and they also act like "smart building blocks" that help construct the baby's immune system and nervous system.

However, not all fats are created equal. The paper highlights a very specific "secret sauce" in human milk fat: Palmitic acid. Think of this fatty acid as a VIP guest at a dinner party. In human milk, this VIP always sits in the sn-2 seat (the middle spot) on the glycerol "table." This specific seating arrangement is crucial because when a baby's digestive system breaks down the fat, the enzymes act like waiters who only serve the food from the outer seats (sn-1 and sn-3). Because the Palmitic acid is safely tucked in the middle seat, it stays attached to the table as a "2-palmitoyl-monoacylglycerol," making it much easier for the baby to absorb and use.

The paper also notes that human milk is a bit of a chameleon; its mix of fats changes depending on what the mother eats and where she lives, particularly in the balance between two other fats: oleic acid and linoleic acid. Additionally, human milk contains a unique mix of medium- and long-chain fats (MLCTs), which are like a hybrid fuel source combining quick energy with long-lasting power.

To solve the problem of creating a substitute for infant formula that mimics this complex recipe, scientists turned to nature's tiny factories: green algae (specifically a type called Auxenochlorella). They genetically engineered these algae to act like custom 3D printers for fat molecules. Instead of just making any old fat, these algae were programmed to build a very specific structure:

1. They pack in the MLCTs (the hybrid fuel).
2. They force the Palmitic acid to sit in the middle (sn-2) seat, just like in human milk.
3. They match the exact ratios of the most common fats found in human milk.

In short, the researchers didn't just make a fat substitute; they engineered a microscopic algae factory to produce a fat that looks and acts structurally almost exactly like the fat found in human breast milk, right down to the specific seating arrangement of its molecules.

Technical Summary

Technical Summary

Problem Statement
Human milk fat (HMF) serves as the primary caloric source for infants, contributing over 50% of total energy intake while providing critical structural and bioactive lipids essential for immune and nervous system development. A defining characteristic of HMF is the regiospecific distribution of palmitic acid, which constitutes 20–25% of its fatty acid profile and is predominantly esterified at the sn-2 position of the glycerol backbone. This specific positioning is physiologically significant because it facilitates the absorption of 2-palmitoyl-monoacylglycerol following the hydrolysis of fatty acids at the sn-1 and sn-3 positions by gut lipases. Furthermore, HMF is enriched in structured medium- and long-chain triacylglycerols (MLCTs), and its oleic-to-linoleic acid ratio varies based on maternal diet and geography. Current infant formulas often lack these specific structural features, potentially limiting their nutritional equivalence to human milk.

Methodology
To address the need for a more physiologically accurate HMF substitute, the authors engineered the oleaginous green alga Auxenochlorella. The study focused on modifying the alga's metabolic pathways to direct the biosynthesis of triacylglycerols (TAGs) that mimic the specific structural and compositional attributes of HMF. The engineering strategy targeted the production of lipids enriched in:

1. Structured medium- and long-chain triacylglycerols (MLCTs).
2. Palmitic acid specifically esterified at the sn-2 position.
3. A fatty acid profile matching the proportions of the most abundant fatty acids found in HMF, including linoleate.

Key Contributions and Results
The research successfully demonstrated the biosynthesis of a tailored HMF substitute using the engineered Auxenochlorella strain. The resulting algal lipids achieved the following:

• Regioisomeric Matching: The engineered lipids replicated the sn-2 palmitate enrichment characteristic of HMF, ensuring the presence of the specific regioisomer required for optimal infant digestion and absorption.
• Structural Enrichment: The product contained a significant proportion of structured MLCTs, aligning with the complex TAG architecture of human milk.
• Fatty Acid Composition: The lipid profile was enriched in linoleate and maintained a ratio of oleic to linoleic acid consistent with HMF variations, while matching the abundance of other major fatty acids found in human milk.

Significance
The paper claims that the engineered Auxenochlorella strain provides a viable biological platform for producing a human milk fat substitute that matches the regioisomeric composition and fatty acid proportions of natural human milk. By replicating the specific structural features of HMF—particularly the sn-2 palmitate and MLCT enrichment—this approach offers a potential solution for improving the nutritional quality of infant formula, thereby better supporting infant immune and nervous system development.